Cargando…
A proof-of-concept study of growth hormone in children with Phelan–McDermid syndrome
BACKGROUND: Phelan–McDermid syndrome (PMS) is caused by 22q13 deletions including SHANK3 or pathogenic sequence variants in SHANK3 and is among the more common rare genetic findings in autism spectrum disorder (ASD). SHANK3 is critical for synaptic function, and preclinical and clinical studies sugg...
Autores principales: | Sethuram, S., Levy, T., Foss-Feig, J., Halpern, D., Sandin, S., Siper, P. M., Walker, H., Buxbaum, J. D., Rapaport, R., Kolevzon, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800321/ https://www.ncbi.nlm.nih.gov/pubmed/35093163 http://dx.doi.org/10.1186/s13229-022-00485-7 |
Ejemplares similares
-
A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome
por: Fastman, J., et al.
Publicado: (2021) -
Neural Markers of Auditory Response and Habituation in Phelan-McDermid Syndrome
por: Isenstein, Emily L., et al.
Publicado: (2022) -
Clinical trial of insulin-like growth factor-1 in Phelan-McDermid syndrome
por: Kolevzon, A., et al.
Publicado: (2022) -
Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
por: Wang, A. Ting, et al.
Publicado: (2016) -
Erratum to: Neural selectivity for communicative auditory signals in Phelan-McDermid syndrome
por: Wang, A. Ting, et al.
Publicado: (2016)